Disney
DIS
Amazon
AMZN
Netflix
NFLX
4
Cisco
CSCO
5
Adobe
ADBE
US Stock MarketDetailed Quotes
NERV Minerva Neurosciences
- 1.5700
- -0.0700-4.27%
Close Mar 10 16:00 ET
- 1.5700
- 0.00000.00%
Post 20:01 ET
10.98MMarket Cap8.26P/E (TTM)
1.6900High1.5300Low33.30KVolume1.6200Open1.6400Pre Close54.01KTurnover0.61%Turnover Ratio8.26P/E (Static)6.99MShares3.690052wk High-0.43P/B8.54MFloat Cap1.420052wk Low--Dividend TTM5.44MShs Float126.7200Historical High--Div YieldTTM9.76%Amplitude1.2600Historical Low1.6210Avg Price1Lot Size
Minerva Neurosciences News
Minerva Neurosciences: Cash, Cash Equivalents and Restricted Cash at Dec 31 Were $21.5M >NERV
Press Release: Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
Minerva Neurosciences 4Q Loss/Shr 56c >NERV
Minerva Neurosciences | 10-K: FY2024 Annual Report
H.C. Wainwright Maintains Minerva Neurosciences(NERV.US) With Hold Rating, Maintains Target Price $5
Minerva Neurosciences: Hold Rating Amid Regulatory Challenges and Uncertain Drug Development
Minerva Neurosciences Reports Positive Earnings Amid FDA Challenges
Minerva Neurosciences: Interactions With FDA Continue With Goal of Addressing Questions Raised in Roluperidone CRL >NERV
Press Release: Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
Express News | Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
Express News | Minerva Neurosciences Q3 Net Income USD 22.513 Million
Minerva Neurosciences | 10-Q: Q3 2024 Earnings Report
Minerva Bunkering Acquires Bomin Group, Expanding U.S. Operations
Minerva Launches Availability of Advanced, Real-time AML Screening Technology in AWS Marketplace
O9 Launches Minerva, a Professional Community Dedicated to Advancing Gender Inclusivity in Supply Chain Leadership
Viamedia and Minerva Networks Partner to Simplify Cross-Platform Ad Delivery With Viamedia's Parrot Software Technology
HC Wainwright & Co. Maintains Neutral on Minerva Neurosciences, Lowers Price Target to $5
Hold Rating on Minerva Neurosciences Amid Regulatory Uncertainty and Financial Constraints
Express News | Minerva Neurosciences Inc : H.c. Wainwright Cuts Target Price to $5 From $7
Minerva Neurosciences 2Q-End Cash, Equivalents, Restricted Cash About $31M >NERV
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now